Orange Book product · Brand (NDA)
MINOCIN
MINOCYCLINE HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
4
Listed patents
Key dates
Today
Patent 12161656 expires
Listed drug product patent expiration.
May 12, 2031
in 5 yr
Patent 9084802 expires
Listed method-of-use patent (U-282) expiration.
May 12, 2031
in 5 yr
Patent 9278105 expires
Listed method-of-use patent (U-282) expiration.
May 12, 2031
in 5 yr
Patent 11944634 expires
Listed drug product patent expiration.
Oct 16, 2032
in 6 yr 5 mo
Pharmaceutical detail
Active ingredient
MINOCYCLINE HYDROCHLORIDE
Strength
EQ 100MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 050444
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2024EMROSIBrand (NDA)
NDA 219015 · JOURNEY
- 2020ZILXIBrand (NDA)
NDA 213690 · JOURNEY
- 2019AMZEEQBrand (NDA)
NDA 212379 · JOURNEY
- 2017MINOLIRABrand (NDA)
NDA 209269 · EPI HLTH
- 2012XIMINOBrand (NDA)
NDA 201922 · JOURNEY
- 2006SOLODYNBrand (NDA)
NDA 050808 · BAUSCH
- 2001ARESTINBrand (NDA)
NDA 050781 · ORAPHARMA
- 1990MINOCINBrand (NDA)
NDA 050649 · BAUSCH
- 1982MINOCYCLINE HYDROCHLORIDEBrand (NDA)
NDA 050451 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050315 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050445 · BAUSCH
- 2022MINOCYCLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215466 · REGCON HOLDINGS
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12161656 | May 12, 2031 | in 5 yr | Product |
| 9084802 | May 12, 2031 | in 5 yr | U-282 |
| 9278105 | May 12, 2031 | in 5 yr | U-282 |
| 11944634 | Oct 16, 2032 | in 6 yr 5 mo | Product |
